Pharmaceutical Production Batch Record Review is organized by The Center for Professional Innovation & Education (CfPIE), Inc. and will be held from Nov 03 - 05, 2026.
Description:
This 15 hour course is intended to take the mystery out of the batch record review process. The class examines the FDA and EU regulatory requirements for documentation and batch record reviews, explains the elements of the batch record review process, and clarifies the pathway to effective deviation investigations. Interactive sessions are included for identifying reviewer responsibilities, establishing good documentation practices, and writing procedures for the review process. Additionally, participants will be able to analyze their company's compliance with these requirements and identify missing elements of the batch review process.
Efficient and effective batch record reviews provide pharmaceutical companies with two strategies. First, reviews are key to maintaining control of your firm's operations, eliminating any guesswork and aiding in the resolution of atypical occurrences. Secondly, they enable a company to maintain and demonstrate a compliant posture - a sure way to avoid any quandary with the regulatory agencies.
?Ample time is provided to address specific problems and questions of individual participants. Additional benefits of this class include:
Learning Objectives:
Upon completion of this course, attendees will gain a clear understanding of the batch record review expectations of regulatory agencies and discover the elements of an effective batch record reviewer training program. Participants will learn how to prepare for a technical review of batch records, as well as how to measure the effectiveness of the review process. In addition to recognizing what to do when a batch fails to meet specifications (deviations), how to determine deviation cause, and corrective and preventive action(s) (CAPA), learners will see the benefits of a working relationship between production and quality reviewers.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved